CUSIP 35104E100COMFDMTQ4 2025
62 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ra Capital Management, L.P. | 5.65M | $42.40M |
| 2 | Janus Henderson Group PLC | 4.64M | $34.73M |
| 3 | Bvf Inc/Il | 4.63M | $34.72M |
| 4 | Goldman Sachs Group Inc | 4.30M | $32.27M |
| 5 | Blackrock, Inc. | 4.06M | $30.49M |
| 6 | Novo Holdings A/S | 3.65M | $27.38M |
| 7 | Vanguard Group Inc | 3.09M | $23.20M |
| 8 | State Street Corp | 2.69M | $20.17M |
| 9 | Armistice Capital, LLC |
| 4 | Feb 17, 2026 | Biotechnology Value Fund L P | 13G/A | 10.0% | 5.85M | SEC |
| 5 | Feb 9, 2026 | The Goldman Sachs Group, Inc. | 13G/A | 11.0% | 4.29M | SEC |
| 6 | Oct 20, 2025 | Novo Holdings A/S | 13G | 6.8% | 3.17M | SEC |
| 7 | Oct 17, 2025 | Blackrock, Inc. | 13G/A | 6.6% | 3.06M | SEC |
| 8 | May 15, 2025 | Venrock Healthcare Capital Partners III, L.P. | 13G/A | 1.5% | 677.6K | SEC |
| 9 | May 15, 2025 | Biotechnology Value Fund L P | 13G/A | 10.0% | 4.63M | SEC |
| 10 | Apr 17, 2025 | Blackrock, Inc. | 13G/A | 7.8% | 3.62M | SEC |
See the full Schedule 13D/13G history for 4d Molecular Therapeutics In.
Unlock full history| 1.94M |
| $14.52M |
| 10 | Federated Hermes, Inc. | 1.61M | $12.07M |